Mexico Interventional Cardiology Devices Market to Reach US$2.14 Billion by 2034, Driven by Rising Cardiovascular Disease and Demand for Minimally Invasive Treatments

Rising heart disease, wider healthcare access and demand for minimally invasive care are driving adoption of advanced stents, catheters, imaging-guided interventions and TAVR systems

Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- "Mexico Interventional Cardiology Devices Market Size, Share Analysis and Forecast Report (2025-2034)" has been added to ResearchAndMarkets.com's offering.

The Mexico interventional cardiology devices market was valued at USD 1.22 billion in 2024 and is projected to reach USD 2.14 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.80% from 2025 to 2034. Market growth is supported by the rising prevalence of cardiovascular disease, increasing demand for advanced cardiac care, broader healthcare access, and continued innovation in minimally invasive treatment technologies.

Key Market Highlights

• Coronary stents accounted for more than 40% of the market during the historical period and are expected to retain a leading position.
• Hospitals and clinics represented the largest end-user segment during the historical period.
• Catheters are projected to record significant growth during the forecast period.
• Drug-eluting stents, imaging-guided interventions, and transcatheter valve technologies are improving procedural precision and patient outcomes.
• Government healthcare initiatives and expanding access to specialized cardiac services are expected to support long-term market development.

Mexico Interventional Cardiology Devices Market Growth Drivers

The growing burden of cardiovascular disease remains a primary driver of demand for interventional cardiology devices in Mexico. Data cited in a Cleveland Clinic survey published in February 2024 identified heart disease as the country's leading cause of death in 2023, with more than 97,000 cases reported by Mexico's National Institute of Statistics and Geography. Greater awareness of cardiac risk factors, early diagnosis, remote monitoring, and preventive care is encouraging healthcare providers and patients to adopt advanced cardiovascular technologies.

Mexico's aging population and the increased incidence of lifestyle-related conditions are also contributing to higher demand for coronary interventions. At the same time, investments in hospitals, catheterization laboratories, diagnostic imaging, and specialist services are expanding access to minimally invasive procedures. These developments are expected to create opportunities for manufacturers of coronary stents, angioplasty balloons, catheters, structural heart devices, plaque-modification systems, and vascular closure products.

Technology Innovation Shapes Market Trends

Product innovation is strengthening the outlook for the Mexico interventional cardiology devices market. Drug-eluting stents, intravascular ultrasound and optical coherence tomography catheters, artificial intelligence-supported diagnostic platforms, and image-guided treatment systems are helping clinicians manage increasingly complex cardiovascular cases.

Industry events are also facilitating collaboration between international manufacturers and regional specialists. At the Solaci Socime Annual Congress in Mexico in August 2025, Kossel presented technologies including the Octoparms Vena Cava Filter, Tanghulu Balloon, and MiStent Coronary Drug-Eluting Stent. The event reflected growing interest in specialized devices for coronary and peripheral interventions.

The adoption of transcatheter aortic valve replacement systems represents another important market trend. In December 2024, Sahajanand Medical Technologies launched its Hydra TAVR system in Mexico. The system incorporates frame markers, a Supra -annular design, and deployment features intended to support procedural control and reduce trauma. Continued uptake of transcatheter valve technologies is expected to increase demand for precision-led structural heart interventions.

Coronary Stents Maintain Product Leadership

Coronary stents are expected to remain the leading product category after accounting for more than 40% of the market during the historical period. Their position is supported by widespread use in coronary artery disease treatment, ongoing improvements in drug-eluting technologies, and growing clinical preference for minimally invasive procedures.

The catheter segment is forecast to experience notable growth as healthcare facilities increase their use of angiography, guiding, intravascular ultrasound, and optical coherence tomography catheters. Other important product categories include structural heart devices, angioplasty balloons, thrombectomy systems, atherectomy devices, embolic protection devices, chronic Total Fina Elf occlusion devices, guidewires, introducer sheaths, balloon inflation devices, and vascular closure systems.

End-User Outlook

Hospitals and clinics held the largest share of the Mexico interventional cardiology devices market during the historical period. Their leadership reflects access to multidisciplinary cardiac teams, advanced imaging infrastructure, operating facilities, and emergency services. Catheterization laboratories and ambulatory surgical centers are also expected to gain importance as demand rises for efficient, lower-trauma procedures and shorter recovery times.

Competitive Landscape

Leading companies are focusing on product development, clinical evidence, strategic investment, and partnerships with healthcare providers. Boston Scientific Corporation supports complex procedures through technologies such as the RotablatorT rotational atherectomy system and SynergyT stent system.

Medtronic offers cardiovascular solutions including the CathWorks FFRangio System, which incorporates artificial intelligence-supported diagnostic capabilities, and the In.PactT AV drug-coated balloon. Abbott supplies atherectomy systems, vessel closure products, coronary technologies, and transcatheter valve solutions. Philips N.V. provides cardiovascular ultrasound, transcatheter therapy imaging, and integrated cardiology informatics designed to improve clinical decision-making and procedural efficiency.

Other prominent participants include Terumo Corporation, B. Braun SE, Integer Holdings Corporation, Teleflex Incorporated, Biosensors International Group, Ltd., and Cook Medical.

Market Outlook

The Mexico interventional cardiology devices market is positioned for sustained expansion through 2034. Rising cardiovascular disease incidence, stronger healthcare infrastructure, technological innovation, and growing adoption of image-guided and minimally invasive cardiac procedures will remain central to market growth. Manufacturers that deliver clinically validated, cost-effective, and precision-focused solutions are expected to Benefit from increasing demand across hospitals, clinics, catheterization laboratories, and ambulatory surgical centers.

Key Attributes

Report Attribute	Details
No. of Pages	200
Forecast Period	2025-2034
Estimated Market Value (USD) in 2025	$1.22 Billion
Forecasted Market Value (USD) by 2034	$2.14 Billion
Compound Annual Growth Rate	5.8%
Regions Covered	Mexico

Key Topics Covered

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology

2 Executive Summary

3 Interventional Cardiology Devices Market Overview
3.1 Latin America Interventional Cardiology Devices Market Overview
3.1.1 Latin America Interventional Cardiology Devices Market Historical Value (2018-2024)
3.1.2 Latin America Interventional Cardiology Devices Market Forecast Value (2025-2034)
3.2 Mexico Interventional Cardiology Devices Market Overview
3.2.1 Mexico Interventional Cardiology Devices Market Historical Value (2018-2024)
3.2.2 Mexico Interventional Cardiology Devices Market Forecast Value (2025-2034)

4 Mexico Interventional Cardiology Devices Market Landscape
4.1 Mexico Interventional Cardiology Devices Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Mexico Interventional Cardiology Devices Market: Product Landscape
4.2.1 Analysis by Product

5 Mexico Interventional Cardiology Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter's Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis

6 Mexico Interventional Cardiology Devices Market Segmentation (2018-2034)
6.1 Mexico Interventional Cardiology Devices Market (2018-2034) by Product
6.1.1 Coronary Stents
6.1.1.1 Bare Metal Stents (BMS)
6.1.1.2 Drug-Eluting Stents (DES)
6.1.1.3 Others
6.1.2 Structural Heart Devices
6.1.3 Angioplasty Balloons
6.1.3.1 Old/Normal Balloons
6.1.3.2 Drug-Eluting Balloons
6.1.3.3 Cutting/Scoring Balloons
6.1.4 Catheters
6.1.4.1 Angiography Catheters
6.1.4.2 Guiding Catheters
6.1.4.3 IVUS/OCT Catheters
6.1.4.4 Others
6.1.5 Plaque modification Devices
6.1.5.1 Thrombectomy Devices
6.1.5.2 Atherectomy Devices
6.1.6 Hemodynamic Flow Alteration Devices
6.1.6.1 Embolic Protection Devices
6.1.6.2 Chronic Total Fina Elf Occlusion Devices
6.1.7 Others Interventional Cardiology Devices
6.1.7.1 Guidewires
6.1.7.2 Vascular Closure Devices
6.1.7.3 Introducer Sheaths
6.1.7.4 Balloon Inflation Devices
6.1.7.5 Hemostasis Heart Valve
6.2 Mexico Interventional Cardiology Devices Market (2018-2034) by End User
6.2.1 Hospitals and Clinics
6.2.2 Ambulatory Surgical Centers (ASCs)
6.2.3 Cath Labs
6.2.4 Others

7 Regulatory Framework

8 Funding and Investment Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography

9 Strategic Initiatives
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Initiatives
9.3 Analysis by Leading Players
9.4 Analysis by Geography

10 Supplier Landscape
10.1 Vendor Positioning Analysis
10.1.1 Key Vendors
10.1.2 Prospective Leaders
10.1.3 Niche Leaders
10.1.4 Disruptors
10.2 Market Share Analysis, By Country (Top 5 Companies)
10.3 Boston Scientific Corporation
10.3.1 Financial Analysis
10.3.2 Product Portfolio
10.3.3 Demographic Reach and Achievements
10.3.4 Company News and Developments
10.3.5 Certifications
10.4 Medtronic plc
10.4.1 Financial Analysis
10.4.2 Product Portfolio
10.4.3 Demographic Reach and Achievements
10.4.4 Company News and Developments
10.4.5 Certifications
10.5 Abbott
10.5.1 Financial Analysis
10.5.2 Product Portfolio
10.5.3 Demographic Reach and Achievements
10.5.4 Company News and Developments
10.5.5 Certifications
10.6 Philips N.V.
10.6.1 Financial Analysis
10.6.2 Product Portfolio
10.6.3 Demographic Reach and Achievements
10.6.4 Company News and Developments
10.6.5 Certifications
10.7 Terumo Corporation
10.7.1 Financial Analysis
10.7.2 Product Portfolio
10.7.3 Demographic Reach and Achievements
10.7.4 Company News and Developments
10.7.5 Certifications
10.8 B. Braun SE
10.8.1 Financial Analysis
10.8.2 Product Portfolio
10.8.3 Demographic Reach and Achievements
10.8.4 Company News and Developments
10.8.5 Certifications
10.9 Integer Holdings Corporation
10.9.1 Financial Analysis
10.9.2 Product Portfolio
10.9.3 Demographic Reach and Achievements
10.9.4 Company News and Developments
10.9.5 Certifications
10.10 Teleflex Incorporated
10.10.1 Financial Analysis
10.10.2 Product Portfolio
10.10.3 Demographic Reach and Achievements
10.10.4 Company News and Developments
10.10.5 Certifications
10.11 Cook Medical
10.11.1 Financial Analysis
10.11.2 Product Portfolio
10.11.3 Demographic Reach and Achievements
10.11.4 Company News and Developments
10.11.5 Certifications
10.12 Biosensors International Group, Ltd.
10.12.1 Financial Analysis
10.12.2 Product Portfolio
10.12.3 Demographic Reach and Achievements
10.12.4 Company News and Developments
10.12.5 Certifications

11 Mexico Interventional Cardiology Devices Market - Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment

12 Key Opinion Leaders (KOL) Insights (Additional Insight)

For more information about this report visit https://www.researchandmarkets.com/r/kkkok5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900